BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $5.39 million. The enterprise value is $427,718.
Important Dates
The next estimated earnings date is Friday, November 29, 2024, before market open.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BGLC has 17.97 million shares outstanding. The number of shares has increased by 20.68% in one year.
| Current Share Class | 17.97M |
| Shares Outstanding | 17.97M |
| Shares Change (YoY) | +20.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.32% |
| Owned by Institutions (%) | 0.88% |
| Float | 13.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.57 |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.60 |
| Quick Ratio | 4.87 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -87.54 |
Financial Efficiency
Return on equity (ROE) is -28.44% and return on invested capital (ROIC) is -12.02%.
| Return on Equity (ROE) | -28.44% |
| Return on Assets (ROA) | -10.11% |
| Return on Capital (ROIC) | -12.02% |
| Revenue Per Employee | $306,106 |
| Profits Per Employee | -$73,513 |
| Employee Count | 30 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 7.19 |
Taxes
In the past 12 months, BGLC has paid $97,178 in taxes.
| Income Tax | 97,178 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.04% in the last 52 weeks. The beta is 1.87, so BGLC's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | -13.04% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 24.55 |
| Average Volume (20 Days) | 79,549 |
Short Selling Information
The latest short interest is 140,383, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 140,383 |
| Short Previous Month | 101,615 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 2.21 |
Income Statement
In the last 12 months, BGLC had revenue of $9.18 million and -$2.21 million in losses. Loss per share was -$0.13.
| Revenue | 9.18M |
| Gross Profit | 1.27M |
| Operating Income | -1.54M |
| Pretax Income | -2.64M |
| Net Income | -2.21M |
| EBITDA | -1.46M |
| EBIT | -1.54M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $5.41 million in cash and $451,450 in debt, giving a net cash position of $4.96 million or $0.28 per share.
| Cash & Cash Equivalents | 5.41M |
| Total Debt | 451,450 |
| Net Cash | 4.96M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 9.55M |
| Book Value Per Share | 0.54 |
| Working Capital | 6.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.87 million and capital expenditures -$158,718, giving a free cash flow of -$2.02 million.
| Operating Cash Flow | -1.87M |
| Capital Expenditures | -158,718 |
| Free Cash Flow | -2.02M |
| FCF Per Share | -$0.11 |
Full Cash Flow StatementMargins
Gross margin is 13.88%, with operating and profit margins of -16.76% and -24.02%.
| Gross Margin | 13.88% |
| Operating Margin | -16.76% |
| Pretax Margin | -22.96% |
| Profit Margin | -24.02% |
| EBITDA Margin | -15.87% |
| EBIT Margin | -16.76% |
| FCF Margin | -14.21% |